AKT1 and cancer: As NTF-3 is known to regulate the PI3K/AKT signaling pathway by binding directly to the TrkC receptor [24,31,32,33,45,48], it is evident that it might have a role in the development of different malignant tumors, but also that its aberrations could be different depending on the type of tumor.